Talha Badar, Hematology/Oncology Specialist at Mayo Clinic, shared a post on X:
” Key abstracts to watch in MDS/CMML:
- Deeper insights into Ven+Aza across high-risk and therapy-related MDS
- Momentum in telomerase inhibitors, TPO agonists & precision-fusion agents
- Emerging immunotherapy strategy for TP53 mutant disease
- Fascinating progress in mitochondrial-transplantation biology for MDS.
- Better-defined treatment frameworks for CMML/overlaps.”
You Can Also Read: Key Abstracts to Watch in ALL at ASH 2025
